|Articles|April 20, 2020
Ripple Science Announces Initiatives During COVID-19
Advertisement
Ripple Science has announced new initiatives to help clinical researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six-months of access free of charge.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
Accelerating Clinical Trial Timelines with AI
3
When AI Learns to Speak Every Language: An eCOA Migration Study
4
ACT Brief: AI’s Impact on Trial Timelines, New Strategies in Obesity R&D, and Why Patient Support Needs a Clinical Backbone
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
